GlassScriptPhysician profile
Farzad Massoudi
NPI 1437144599
$755,710.68
in general payments reported to CMS, 2019-2025
44 companies · $119K in 2025
The $119K reported for 2025 was more than what 98% of Neurological Surgery providers received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $125K · 2020: $99K · 2021: $98K · 2022: $114K · 2023: $98K · 2024: $104K · 2025: $119K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $317K · Food and Beverage: $2,460 · Travel and Lodging: $1,031.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $317,220.54 |
| Food and Beverage | $2,460.04 |
| Travel and Lodging | $1,031.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biogennix, LLC | $739,964.13 | 2019-2025 | Morpheus, Agilon Surgical Matrix, Agilon |
| Globus Medical, INC. | $11,494.90 | 2019-2025 | Sp-Fix, Senza, Excelsius3d Imaging System |
| Spineology INC. | $1,078.52 | 2023-2025 | Optimesh Expandable Interbody Fusion System |
| Precision Spine, INC. | $508.22 | 2019 | |
| Medtronic USA, INC. | $276.38 | 2019-2020 | |
| Stryker Corporation | $258.81 | 2019-2025 | Universal Neuro 3, N/A |
| 7d Surgical INC. | $222.80 | 2020 | |
| Bioventus LLC | $138.17 | 2022-2025 | Sonastar, Bonescalpel, Bonescalpel & Sonicone (O.R.) |
| Carlsmed, INC. | $127.00 | 2024 | Aprevo |
| Biotronik Nro, INC. | $122.59 | 2024-2025 | Prospera |
| Nuvasive, INC. | $121.20 | 2019-2023 | Simplify Cervical Artificial Disc, Acp |
| Baxter Healthcare | $112.68 | 2020-2024 | Floseal |
| Abbvie INC. | $104.62 | 2023-2025 | |
| Ethicon US, LLC | $98.44 | 2020-2022 | |
| Abbott Laboratories | $97.93 | 2023-2025 | Eterna, Proclaim, Infinity |
Show all 44 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimvie INC. | $74.89 | 2022-2023 | |
| Augmedics INC. | $70.97 | 2023 | Xvision |
| Icotec Medical INC. | $70.25 | 2025 | Vader Pedicle System 6.0, Screw, Carbon/Peek, Polyax., Fen., O 5.5 X 45 Mm, Vader Pedicle System, Rod, Carbon/Peek, Curved, 6.0 R450 X 200 Mm, Kong-Tl Vbr, End Plate, Rectangular, M and Screw, 12 X 33 Mm |
| Intrinsic Therapeutics | $68.18 | 2025 | Barricaid Acd (Annular Closure Device) |
| Integra Lifesciences Corporation | $66.96 | 2020-2022 | |
| Depuy Synthes Sales INC. | $66.69 | 2019-2021 | |
| Saluda Medical Americas, INC. | $55.72 | 2024 | Evoke |
| Zimmer Biomet Holdings, INC. | $49.71 | 2019 | |
| Si-Bone, INC. | $42.08 | 2021-2022 | |
| Omniscient Neurotechnology America LTD | $37.05 | 2023 | Quicktome |
| Boston Scientific Corporation | $30.46 | 2019-2020 | |
| Varian Medical Systems, INC. | $27.77 | 2019 | |
| Neo Spine USA, INC. | $25.78 | 2022 | |
| Analogic Corporation | $25.68 | 2019 | |
| Nevro Corp. | $25.17 | 2019 | |
| Biotronik INC. | $22.98 | 2020 | |
| Highridge Medical LLC | $21.64 | 2024 | Roi-C |
| Curonix LLC | $21.51 | 2024 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Davol INC. | $20.73 | 2024 | Arista Ah Flexitip |
| Gt Medical Technologies, INC | $20.00 | 2020 | |
| Smith+Nephew, INC. | $18.13 | 2022 | |
| Medtronic, INC. | $17.98 | 2022 | |
| Spinal Simplicity, LLC | $17.47 | 2022 | |
| Arteriocyte Medical Systems, INC. | $17.33 | 2024 | Magellan |
| Kls-Martin L.P. | $16.48 | 2021 | |
| Aesculap, INC. | $15.00 | 2020 | |
| Lemaitre Vascular, INC. | $14.58 | 2021 | |
| Misonix INC | $11.71 | 2021 | |
| Ossdsign USA Incorporated | $11.39 | 2025 | Ossdsign Catalyst |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Farzad Massoudi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.